Wei Jing Liu
Overview
Explore the profile of Wei Jing Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1372
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Z, Zhang Z, Wang Y, Xie J, Li Y, Shen C, et al.
Front Physiol
. 2025 Feb;
16:1541198.
PMID: 39958689
Aim: Advanced glycation end products (AGEs) are pivotal mediators in diabetic kidney disease (DKD). However, their prognostic utility remains underexplored. This study introduced corrected lgAGEs [novel biomarker derived by adjusting...
2.
Wu Y, Wang Y, Huang W, Guo X, Hou B, Tang J, et al.
Front Pharmacol
. 2024 Sep;
15:1411933.
PMID: 39253380
Introduction: We investigated the efficacy and safety of oral sodium bicarbonate in kidney-transplant recipients and non-transplant patients with chronic kidney disease (CKD), which are currently unclear. Methods: PubMed, Cochrane Library,...
3.
Zhang S, Zhang Y, Bai X, Zhou M, Zhang Z, Zhang S, et al.
Drug Des Devel Ther
. 2024 May;
18:1439-1457.
PMID: 38707616
Background: Acteoside, an active ingredient found in various medicinal herbs, is effective in the treatment of diabetic kidney disease (DKD); however, the intrinsic pharmacological mechanism of action of acteoside in...
4.
Qiyan Zheng , Zhang X, Guo J, Wang Y, Jiang Y, Li S, et al.
J Ethnopharmacol
. 2024 Feb;
328:117863.
PMID: 38325670
Ethnopharmacological Relevance: The JinChan YiShen TongLuo (JCYSTL) formula, a traditional Chinese medicine (TCM), has been used clinically for decades to treat diabetic nephropathy (DN). TCM believes that the core pathogenesis...
5.
Guo J, Tian X, Liu H, Liu W
Front Endocrinol (Lausanne)
. 2024 Jan;
14:1349432.
PMID: 38164495
No abstract available.
6.
Han Y, Zheng H, Du B, Zhang Y, Zhu X, Li J, et al.
J Diabetes Res
. 2023 Dec;
2023:8871677.
PMID: 38094870
Diabetic kidney disease (DKD) is a prevailing complication arising from diabetes mellitus. Unfortunately, there are no trustworthy and efficacious treatment modalities currently available. In recent times, compelling evidence has emerged...
7.
Yu B, Zhou M, Dong Z, Zheng H, Zhao Y, Zhou J, et al.
Pharm Biol
. 2023 Aug;
61(1):1222-1233.
PMID: 37565668
Context: Diabetic nephropathy (DN) is the main cause of end-stage renal disease. Modified Shen-Yan-Fang-Shuai formula (M-SYFSF) has excellent clinical efficacy in treating diabetic kidney disease. However, the potential mechanism of...
8.
Ai S, Li Y, Tao J, Zheng H, Tian L, Wang Y, et al.
Front Physiol
. 2023 Jun;
14:1176894.
PMID: 37362429
The gut-kidney axis refers to the interaction between the gastrointestinal tract and the kidneys, and its disorders have become increasingly important in the development of kidney diseases. The aim of...
9.
Qiu Y, Tang J, Zhao Q, Jiang Y, Liu Y, Liu W
J Diabetes Res
. 2023 Jun;
2023:3931043.
PMID: 37287620
Background: Diabetic nephropathy (DN) is a major cause of end-stage renal disease (ESRD), and there is growing evidence to support the role of immunity in the progression of DN to...
10.
Xue C, Zhou M, Zheng Q, Zhang J, Cheng W, Bai X, et al.
Front Cardiovasc Med
. 2022 Dec;
9:1043406.
PMID: 36523368
Systematic Review Registration: [https://www.crd.york.ac.uk/prospero/], identifier [CRD42021231663].